Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of AKTX opened at $0.93 on Monday. The firm has a 50 day simple moving average of […]
Stock analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of AKTX opened at $0.93 on Monday. The firm has a 50 day simple moving average of […]
